A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
This research study is looking at a medication called vatiquinone for people living with Friedreich Ataxia. It's specifically for individuals who have previously taken part in another vatiquinone study. The main goal is to check the long-term safety of the medicine and see if it continues to be helpful over a longer period. This study allows participants to continue receiving vatiquinone, addressing a need for ongoing treatment. Researchers will be monitoring the effects of the medication over about three years. If you've been in a vatiquinone study before, this might be a way to keep receiving the treatment and contribute to understanding its long-term benefits.
במבט חטוף
על מה המחקר הזה?
This study is about a medicine called vatiquinone, which is being investigated for people who have a condition called Friedreich Ataxia. Friedreich Ataxia is a rare inherited disease that affects the nervous system, causing problems with movement and coordination.
The main aim of this study is to look at the long-term safety of vatiquinone. Since you would have been in a previous study with this medicine, the researchers want to continue watching how it affects you over a longer period. They also want to see if it continues to help with the symptoms of Friedreich Ataxia.
This study is designed to offer continued access to vatiquinone for people who have already used it in a clinical trial. This means that if you found the medicine helpful, you might be able to carry on taking it for about three years, while doctors continue to gather important information about its effects. This helps doctors understand if the medicine is a good long-term option for people with Friedreich Ataxia.
נקודות עיקריות
- This study is for people with Friedreich Ataxia who have already used vatiquinone in a past study.
- It aims to check the long-term safety and effectiveness of vatiquinone over about three years.
- Participation means continued access to the study medicine and regular health check-ups.
- Contraception is required for men and women who could have children.
- You cannot be taking part in another treatment study or be pregnant/breastfeeding.
מי עשוי להיות זכאי?
To join this study, you must have Friedreich Ataxia and have already completed a previous research study involving the medicine vatiquinone. It's important that you move directly from that previous study into this one.
If you are a man or woman who could have children, you must agree to use effective contraception (birth control) throughout the study and for 30 days after your last dose of the medicine. This is to prevent pregnancy during the study.
You cannot join this study if you are already taking part in another clinical trial where you are receiving a treatment. Also, you cannot be pregnant or breastfeeding.
האם מחקר זה יכול להתאים לך?
ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.
- Do I have Friedreich Ataxia?
- Have I already completed a previous study with vatiquinone?
- Am I willing to use effective birth control if I could have children?
- Am I currently pregnant or breastfeeding?
- Am I participating in any other treatment study right now?
מה כרוך בהשתתפות?
If you decide to take part, you will be given the study medicine, vatiquinone, which you would have taken in a previous study. You will continue to have regular check-ups with the study team over approximately three years. These visits will involve various tests and assessments to monitor your health, how the medicine is working, and to check for any side effects. The study team will explain exactly what each visit involves, but it's important to remember that this is a long-term commitment, likely involving regular trips to the clinic or hospital.
סיכונים ותועלות פוטנציאליים
מיקומים (14)
- UCLAמיקוד מאומתלוס אנג'לס, ארצות הברית
- University of Floridaמיקוד מאומתגיינסוויל, ארצות הברית
- אוניברסיטת דרום פלורידהמיקוד מאומתטמפה, ארצות הברית
- University of Iowaמיקוד מאומתאיווה סיטי, ארצות הברית
- The Children's Hospital of Philadelphiaמיקוד מאומתפילדלפיה, ארצות הברית
- Murdoch Children's Research Instituteמיקוד מאומתParkville, Australia
- University of Campinas (UNICAMP) - School of Medical Sciences, Dept of Neurologyמיקוד מאומתSão Paulo, Brazil
- Centre de Recherche du Centre Hospitalier de l'Université de Montreal (CRCHUM)מיקוד מאומתמונטריאול, קנדה
- CHU Sainte-Justineמיקוד מאומתמונטריאול, קנדה
- Hôpital Pitié-Salpêtrière, Institut du Cerveau (Paris Brain Institute)מיקוד מאומתפריז, צרפת
- Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE)מיקוד מאומתטיבינגן, גרמניה
- Ospedale Pediatrico Bambino Gesu' IRCCSמיקוד מאומתרומא, איטליה
שאלות נפוצות
What is Friedreich Ataxia?
Friedreich Ataxia is a condition that affects the nervous system, causing problems with balance, coordination, and movement.
What is vatiquinone?
Vatiquinone is a medicine being studied to see if it can help people with Friedreich Ataxia.
האם אקבל את התרופה האמיתית או כדור דמה?
Because you've been in a previous study and this is continuing access, you will receive the actual medicine, vatiquinone.
כמה זמן יימשך המחקר?
This study is planned to last for about three years.
האם אני יכול לעזוב את המחקר אם אשנה את דעתי?
Yes, you can leave the study at any time, and you don't have to give a reason. Your medical care won't be affected.
כיצד לגלות עוד
תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.
דיון
דיון קהילתי
מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.